Specific targeting of CD33+ leukemia cells by a natural killer cell line modified with a chimeric receptor
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference27 articles.
1. Tumor-specific T-bodies: towards clinical application;Eshhar;Cancer Immunol. Immunother.,1997
2. An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability;Whitlow;Protein Eng.,1993
3. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients;Riddell;Nat. Med.,1996
4. Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptor;McGuinness;Hum. Gene Ther.,1999
5. T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells;Hombach;Gene Ther.,2001
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. CAR-NK cell therapy in AML: Current treatment, challenges, and advantage;Biomedicine & Pharmacotherapy;2024-08
2. Natural killer cells and acute myeloid leukemia: promises and challenges;Cancer Immunology, Immunotherapy;2022-05-31
3. CAR-NK cells for cancer immunotherapy: from bench to bedside;Biomarker Research;2022-03-18
4. Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a review;Expert Opinion on Biological Therapy;2021-10-22
5. Stem cell–derived CAR T cells traffic to HIV reservoirs in macaques;JCI Insight;2021-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3